2026. DEVELOPMENT OF TARGETED NANOPARTICLE DRUG DELIVERY FOR SURGICAL CANCER THERAPY: EFFECTS ON PHARMACOKINETICS, TUMOR ACCUMULATION, THERAPEUTIC EFFICACY, AND SYSTEMIC TOXICITY. Bioscience Insights. 3, 02 (Aug. 2026), 854–864.